Healthcare & Life Sciences

RheoDx

deadseed
seed
Stage
1
Investors

About

RheoDx develops a medical device for the early diagnosis of sepsis and other inflammatory diseases by analyzing the rheological properties of blood. Their technology aims to provide rapid, accurate, and cost-effective diagnostic results.

Explore RheoDx's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.